Terkko Navigator / Lancet Respiratory Medicine

Critical care trainees call for pulse oximetry reform

Successful double-lung transplantation from a donor previously infected with SARS-CoV-2

When should the UK lift its lockdown?

Delayed-onset myocarditis following COVID-19

Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study

Into the abyss

Separation—a letter to my child

The Troublemaker

Correction to Lancet Respir Med 2021; 9: 85–95

Correction to Lancet Respir Med 2021; published online Jan 28. https://doi.org/10.1016/

Trends in COVID-19-related in-hospital mortality: lessons learned from nationwide samples

Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data

COVID-19 survivor experiencing long-term symptoms

COVID-19 in the Caribbean

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Bearing witness in the time of COVID

A tribute to the gang

Oxygen supplies and COVID-19 mortality in Africa

How could we forget?

Neutrophilic asthma: misconception or misnomer?

Correction to Lancet Respir Med 2020; 8: 873–84

Algeria's response to COVID-19: an ongoing journey

Provision of holistic care after severe COVID-19 pneumonia – Authors' reply

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

COVID-19: a heavy toll on health-care workers

Yemen: Coronavirus in a War Zone

Provision of holistic care after severe COVID-19 pneumonia

COVID-19 vaccination in athletes: ready, set, go…

Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement

High oxygen flow rates with the UCL Ventura CPAP device – Authors' reply

High oxygen flow rates with the UCL Ventura CPAP device

Caution advised regarding lung recruitment before surfactant

The Biden administration: changing the tide for health?

Geography, generalisability, and susceptibility in clinical trials

SARS-CoV-2 evolution and vaccines: cause for concern?

Bronchial thermoplasty: 10 years and counting

Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials

Instrumental dead space in ventilator management

Instrumental dead space in ventilator management – Authors' reply

Long-term safety and efficacy of lumacaftor–ivacaftor therapy in children aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study

Living with bronchiectasis during the COVID-19 pandemic

Correction to Lancet Respir Med 2021; published online Jan 8. https://doi.org/10.1016/S2213-2600(20)30552-X

Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial

New and old treatments for malignant mesothelioma: not just immunotherapy

Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial

Correction to Lancet Respir Med 2020; published online Dec 22. https://doi.org/10.1016/S2213-2600(20)30414-8

Use of point-of-care testing for respiratory viruses in hospital

Touch, and the absence of it

Untouched

Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia